Baqsimi 3 mg nasal powder intranasal device Images
Generic Name: glucagon
This medication has been identified as Baqsimi 3 mg nasal powder intranasal device. It is supplied by Eli Lilly and Company.
Baqsimi is used in the treatment of Hypoglycemia and belongs to the drug class glucose elevating agents. There is no proven risk in humans during pregnancy. Baqsimi 3 mg nasal powder intranasal device is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Baqsimi
- Generic Name
- glucagon
- Strength
- 3 mg nasal powder intranasal device
- Availability
- Prescription only
- Drug Class
- Glucose elevating agents
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Eli Lilly and Company
- National Drug Code (NDC)
- 00002-6145
See also:
Gvoke
Gvoke is used subcutaneously to treat very low blood sugar (severe hypoglycemia) in people with ...
Zegalogue
Zegalogue (dasiglucagon) is used for the treatment of severe hypoglycemia in diabetes patients ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
More about Baqsimi (glucagon)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: glucose elevating agents
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.